HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neutrogena Is “#1 Dermatologist Recommended,” To Unilever’s Chagrin

This article was originally published in The Rose Sheet

Executive Summary

Neutrogena is indeed the No. 1 brand recommended by dermatologists and may in most cases include the claim in its advertising for individual products, the National Advertising Division says July 30, siding against challenger Unilever

You may also be interested in...



Dermatologist Survey Lacked Details, Choices To Support Neutrogena ‘#1 Recommended’ Claim

J&J failed to convince BBB National Program’s appeals panel a 2008 NAD decision supporting its “#1 dermatologist recommended” claim for Neutrogena should preclude another review. Panel says market has changed in 12 years since review of Unilever challenge and L’Oreal could make its own challenge.

Once Was Enough For J&J In Supporting Neutrogena ‘#1 Recommended’ Advertising

J&J Consumer appeals National Advertising Division decision, arguing a “#1 claim” for its Neutrogena personal care line challenged by L’Oréal USA is materially similar to one that NAD attorneys found it supported more than a decade ago.

Beiersdorf Is Having Record Year For Sun Care, Seeing China Recovery, But Full-Year Outlook Is Guarded

The Hamburg, Germany-based firm defied economic and political headwinds and China troubles in the fiscal 2022 first half to book organic net sales growth of 10.5% to 4.5bn worldwide. Despite optimism about China recovery, sun care, and its recent Chantecaille acquisition, Beiersdorf is projecting a slowdown in the second half in what remains a volatile operating environment.

Latest News
See All
UsernamePublicRestriction

Register

RS015583

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel